{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-032947","form_type":"8-K","ticker":"ALDX","cik":"0001341235","company_name":"Aldeyra Therapeutics, Inc.","filed_at":"2025-04-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.022232+00:00","generated_at":"2026-05-23T11:39:59.242160+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Aldeyra Therapeutics appoints Chip Clark to board of directors","bullets":["William (Chip) Clark elected as Class I director on April 17, 2025; term expires at 2027 annual meeting.","Board size increased to eight upon Clark's election.","Clark received option to purchase 76,760 shares at closing price on April 17, 2025, vesting over 3 years.","Annual director fee of $40,000 plus eligibility for annual option grant worth ~$130,000.","Clark is co-founder/CEO of Vibrant Biomedicines, former CEO of Genocea Biosciences."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-032947","json":"https://secwatch.observer/filing/0001213900-25-032947.json","markdown":"https://secwatch.observer/filing/0001213900-25-032947.md","text":"https://secwatch.observer/filing/0001213900-25-032947.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1341235/000121390025032947/0001213900-25-032947-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1341235/000121390025032947/ea023875601-8k_aldey.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T11:39:59.242160+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3a7be6c82a","claim":"William (Chip) Clark was elected as Director at Aldeyra Therapeutics, Inc..","evidence_excerpt":"the Board elected William (Chip) Clark as a Class I director","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1341235/000121390025032947/0001213900-25-032947-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}